Article
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2…
eLife · 2015
Key facts
| Title | Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors |
|---|---|
| Journal | eLife |
| Published | Oct 22, 2015 |
| DOI | 10.7554/eLife.10279 |
| Devices mentioned | 201746 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1